Evidence map›Paper›PMID 27476547›Full record

ArticleAIDS research and human retroviruses2017

Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans.

Matthew J Feinstein, June-Ho Kim, Prossy Bibangambah, Ruth Sentongo, Jeffrey N Martin, Alexander C Tsai, David R Bangsberg, Linda Hemphill, Virginia A Triant, Yap Boum and 3 more

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 6 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 6 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. ComparingAIDS care · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Matthew J Feinstein1 Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine , Chicago, Illinois.
June-Ho Kim2 Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts.
Prossy Bibangambah3 Faculty of Medicine, Mbarara University of Science and Technology , Mbarara, Uganda .
Ruth Sentongo3 Faculty of Medicine, Mbarara University of Science and Technology , Mbarara, Uganda .
Jeffrey N Martin4 Division of Infectious Diseases, Department of Medicine, University of California-San Francisco , San Francisco, California.
Alexander C Tsai5 Center for Global Health , Massachusetts General Hospital, Boston, Massachusetts.
David R Bangsberg3 Faculty of Medicine, Mbarara University of Science and Technology , Mbarara, Uganda .
Linda Hemphill7 Harvard Medical School , Boston, Massachusetts.
Virginia A Triant6 Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts.
Yap Boum9 Epicentre Research Base , Mbarara, Uganda .
Peter W Hunt4 Division of Infectious Diseases, Department of Medicine, University of California-San Francisco , San Francisco, California.
Samson Okello3 Faculty of Medicine, Mbarara University of Science and Technology , Mbarara, Uganda .
Mark J Siedner5 Center for Global Health , Massachusetts General Hospital, Boston, Massachusetts.
Mbarara University of Science and Technology · UGMassachusetts General Hospital · USBrigham and Women's Hospital · USCenter for Global Health · USEpicentre Uganda · UGHarvard University · USNorthwestern University · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
Social Networks, HIV Stigma, and the HIV Care Cascade in Rural UgandaR01MH113494 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TSAI, ALEXANDER C · 2017 to 2021
$3.2M
Developing Research At The Interface Of HIV And AgingR24AG044325 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HIGH, KEVIN P. · 2013 to 2017
$2.4M
Behavioral Aspects of Low-cost Medical Devices to Improve HIV CareK23MH099916 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2013 to 2017
$917k
Evaluation and development of cardiovascular risk prediction algorithms in HIVR56HL125029 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TRIANT, VIRGINIA ATHENA · 2014 to 2014
$821k
Epidemiology of atherosclerosis among older-age individuals with HIV in UgandaR21HL124712 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2014 to 2015
$332k
NHLBI NIH HHS R21 HL124712NHLBI NIH HHS R56 HL125029NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI060354NIA NIH HHS R24 AG044325NIMH NIH HHS K23 MH099916NIMH NIH HHS R01 MH054907NIMH NIH HHS R01 MH113494
6 · The paper itself

Abstract

Preventable cardiovascular disease (CVD) risk factors are responsible for the majority of CVD-related deaths, and are increasingly recognized as a cause of morbidity and mortality for HIV-infected persons taking antiretroviral therapy (ART). Simplified tools such as the American Heart Association's ideal cardiovascular health (iCVH) construct may identify and prognosticate CVD risk in resource-limited settings. No studies have evaluated iCVH metrics in sub-Saharan Africa or among HIV-infected adults. Thus, the central aim of this study was to compare levels of iCVH metrics and their correlations with carotid atherosclerosis for HIV-infected adults versus uninfected controls in a well-phenotyped Ugandan cohort. We analyzed the prevalence of iCVH metrics in a mixed cohort of HIV-infected persons on stable ART and uninfected, population-based comparators in Mbarara, Uganda. We also assessed the validity of iCVH by correlating iCVH values with common carotid intima media thickness (CCIMT). HIV-infected persons had a mean of 4.9 (SD 1.1) iCVH metrics at ideal levels versus 4.3 (SD 1.2) for uninfected controls (p = .002). This difference was largely driven by differences in blood pressure, blood glucose, and diet. In multivariable-adjusted linear regression models, each additional iCVH metric at an ideal level was associated with a significant 0.024 mm decrease in CCIMT (p < .001).HIV-infected persons on ART in rural Uganda had more iCVH metrics at ideal levels than uninfected persons. The difference appeared driven by factors that are putatively influenced by access to routine medical care. Composite scores of iCVH metrics were associated with subclinical atherosclerosis and more predictive of atherosclerosis for uninfected persons.

Indexed as

Decision Support TechniquesBiostatisticsCarotid Artery DiseasesCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedUgandacardiovascular diseaseepidemiologyhuman immunodeficiency virusideal cardiovascular healthprimary preventionrisk factors

Identifiers

PMID27476547
PMCPMC5240009
OpenAlexW2482557773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.